ArticleBMC cancer2019
A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.
Chaoyang Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it